Literature DB >> 1685119

Dopamine D1 and D2 receptor agonists induce opposite changes in the firing rate of ventral pallidal neurons.

R J Maslowski1, T C Napier.   

Abstract

Selective dopamine D1 and D2 agonists were used to determine the contributions of each receptor subtype in the modulation of firing rate of ventral pallidum/substantia innominata (VP/SI) neurons. Administration of cumulative doses of the D2 agonist, quinpirole, decreased activity in 59% of the VP/SI cells tested. The decrease in firing rate was dose-dependent between 0.002-0.2 mg/kg i.v. and was blocked by the D2 antagonist, sulpiride (12.5 mg/kg i.v.). In addition, the magnitude and the distribution of responses of VP/SI neurons was not changed following administration of quinpirole as a single versus a divided cumulative dose of 0.1 mg/kg. In contrast, administration of the D1 agonist, SKF38393, excited 69% of the neurons sampled. Similar maximal responses were observed following administration of either a single or a divided cumulative dose of 3.2 mg/kg of SKF38393. The D1 receptor antagonist, SCH23390 (0.1-0.4 mg/kg i.v.) often attenuated the SKF38393-induced increases. The results illustrate that, (1) VP/SI neurons are sensitive to systemically administered dopamine agonists, (2) D1 or D2 receptor activation is sufficient to change the activity of these neurons and (3) these selective agonists mediate opposite effects on VP/SI neuronal activity. These differential responses contrast with effects observed for other dopaminoceptive brain regions, and distinguish VP/SI neurons from morphologically related neurons of the dorsal globus pallidus.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1685119     DOI: 10.1016/0014-2999(91)90672-d

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  7 in total

1.  Delayed-non-match-to-sample performance in the radial arm maze: effects of dopaminergic and gabaergic agents.

Authors:  J J Chrobak; T C Napier
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

Review 2.  The ventral pallidum: Subregion-specific functional anatomy and roles in motivated behaviors.

Authors:  David H Root; Roberto I Melendez; Laszlo Zaborszky; T Celeste Napier
Journal:  Prog Neurobiol       Date:  2015-04-06       Impact factor: 11.685

3.  Long-term treatment with low doses of the D1 antagonist NNC 756 and the D2 antagonist raclopride in monkeys previously exposed to dopamine antagonists.

Authors:  H Lublin; J Gerlach; F Mørkeberg
Journal:  Psychopharmacology (Berl)       Date:  1994-04       Impact factor: 4.530

4.  Opioid and GABA modulation of accumbens-evoked ventral pallidal activity.

Authors:  J J Chrobak; T C Napier
Journal:  J Neural Transm Gen Sect       Date:  1993

5.  Dopamine modulates the responsivity of mediodorsal thalamic cells recorded in vitro.

Authors:  A Lavin; A A Grace
Journal:  J Neurosci       Date:  1998-12-15       Impact factor: 6.167

Review 6.  kappa-Opioid receptor signaling and brain reward function.

Authors:  Adrie W Bruijnzeel
Journal:  Brain Res Rev       Date:  2009-10-02

7.  Dichotomous Dopaminergic Control of Ventral Pallidum Neurons.

Authors:  Martin Clark; Enrico Bracci
Journal:  Front Cell Neurosci       Date:  2018-08-22       Impact factor: 5.505

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.